Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies
- 5 June 2023
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 62 (6) , 819-833
Abstract
Objective To investigate the association of single nucleotide polymorphisms (SNPs) of various genes known to influence mean daily warfarin dose (MDWD) in the Han Chinese population. Methods The study is a systematic review and meta-analysis. Selected studies retrieved by searching Pubmed, Embase (Ovid), Medline, CNKI, Wanfang data, and SinoMed (from their inception to 31 August 2022) for the cohort studies assessing genetic variations that may possibly influence MDWD in Chinese patients were included. Result A total of 46 studies including a total of 10,102 Han Chinese adult patients were finally included in the meta-analysis. The impact of 20 single nucleotide polymorphisms (SNPs) in 8 genes on MDWD was analyzed. The significant impact of some of these SNPs on MDWD requirements was demonstrated. Patients with CYP4F2 rs2108622 TT, EPHX1 rs2260863 GC, or NQO1 rs1800566 TT genotype required more than 10% higher MDWD. Furthermore, patients with ABCB1 rs2032582 GT or GG, or CALU rs2290228 TT genotype required more than 10% lower MDWD. Subgroup analysis showed that patients with EPHX1 rs2260863 GC genotype required 7% lower MDWD after heart valve replacement (HVR). Conclusion This is the first systematic review and meta-analysis assessing the association between single nucleotide polymorphisms (SNPs) of various genes known to influence MDWD besides CYP2C9 and VKORC1 in the Han Chinese population. CYP4F2 (rs2108622), GGCX (rs12714145), EPHX1 (rs2292566 and rs2260863), ABCB1 (rs2032582), NQO1 (rs1800566), and CALU (rs2290228) SNPs might be moderate factors affecting MDWD requirements. Registered information PROSPERO International Prospective Register of Systematic Reviews (CRD42022355130).Keywords
Funding Information
- China National Key R&D Program (2020YFC2008305)
This publication has 52 references indexed in Scilit:
- Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacementEuropean Journal of Clinical Pharmacology, 2013
- Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in chinese valve replacement patientsJournal of Cardiothoracic Surgery, 2012
- Predicting Warfarin Dosage in European–Americans and African–Americans using DNA Samples Linked to an Electronic Health RecordPharmacogenomics, 2012
- CYP4F2rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacementBritish Journal of Clinical Pharmacology, 2010
- A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African AmericansClinical Pharmacology & Therapeutics, 2010
- Association of warfarin dose with genes involved in its action and metabolismHuman Genetics, 2006
- The Inhibitory Effect of Calumenin on the Vitamin K-dependent γ-Carboxylation SystemJournal of Biological Chemistry, 2004
- Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factorsThe Pharmacogenomics Journal, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- A molecular mechanism for genetic warfarin resistance in the ratThe FASEB Journal, 2001